Ilham Y. Abdi

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Distinct Molecular Mechanisms Underlie Modulation of Seeded α-Synuclein Aggregation and Toxicity by Salvianolic Acid B and Dihydromyricetin.

Distinct Molecular Mechanisms Underlie Modulation of Seeded α-Synuclein Aggregation and Toxicity by Salvianolic Acid B and Dihydromyricetin.

Journal: International journal of molecular sciences

Published: March 08, 2026

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Journal: Journal of Parkinson's disease

Published: October 03, 2025

Investigating the prevalence of the G2019S mutation in Parkinson's disease among a Libyan population.

Investigating the prevalence of the G2019S mutation in Parkinson's disease among a Libyan population.

Journal: Journal of Parkinson's disease

Published: March 22, 2025

Seeding amplification assay: Limitations and insights for enhanced clinical and research applications.

Seeding amplification assay: Limitations and insights for enhanced clinical and research applications.

Journal: Journal of Parkinson's disease

Published: March 03, 2025

In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar.

In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar.

Journal: Journal of infection and public health

Published: December 10, 2024

Uncovering a neurological protein signature for severe COVID-19.

Uncovering a neurological protein signature for severe COVID-19.

Journal: Neurobiology of disease

Published: February 16, 2023

Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up.

Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up.

Journal: Neurobiology of disease

Published: November 25, 2022

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.

Journal: International journal of molecular sciences

Published: September 22, 2022

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 30, 2022

Immune-related biomarkers for Parkinson's disease.

Immune-related biomarkers for Parkinson's disease.

Journal: Neurobiology of disease

Published: February 09, 2022

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.

Journal: Neurology

Published: November 20, 2021

Prion-like α-synuclein pathology in the brain of infants with Krabbe disease.

Prion-like α-synuclein pathology in the brain of infants with Krabbe disease.

Journal: Brain : a journal of neurology

Published: October 20, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026